Research Paper Volume 12, Issue 1 pp 912—930
Prognostic potential of PRPF3 in hepatocellular carcinoma
Figure 3. PRPF3 is associated with survival outcome. (A) Overall survival (OS) and disease-free survival (DFS) in TCGA LIHC cohort. (B) OS and DFS of PRPF3 in GSE14520 cohort. The numbers below the figures denote the number of patients at risk in each group.